Cancer-fighter ImmunoGen, Inc. Raises About $24 Million
Biopharmaceutical company ImmunoGen Inc., which develops cancer-fighting therapies, said Monday it raised about $25 million after selling 7.8 million shares of the company’s stock to Ziff Asset Management.